# BUPIVACAINE HCl

NDC: 51662-1592
Generic name: BUPIVACAINE HCl
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INFILTRATION, PERINEURAL
Marketing started: 20220713

FDA application: NDA018304

## Active ingredients

- BUPIVACAINE HYDROCHLORIDE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1592"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1592
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e391f807-7699-6d82-e053-2a95a90ab641